Skin cancer is the most common type of cancer in the United States and many other countries. It mainly develops when skin cells are damaged, often by long-term exposure to sunlight.
The two most common types are basal cell carcinoma and squamous cell carcinoma. These cancers usually grow slowly and are less dangerous than melanoma, but they can still cause serious problems if not treated early.
Each year, millions of people are diagnosed with these skin cancers. According to the American Cancer Society, there are about 5.4 million cases of basal cell carcinoma and squamous cell carcinoma every year in the United States.
Basal cell carcinoma makes up around 80 percent of these cases. Although most people survive these cancers, thousands still die from them each year.
Because skin cancer is so common, scientists are always looking for ways to reduce the risk. A recent study has found that a well-known diabetes drug called metformin may help protect against these types of skin cancer.
Metformin is a medicine that has been used for many years to treat type 2 diabetes. It helps control blood sugar levels by improving how the body uses insulin and by reducing the amount of sugar made by the liver. It is widely prescribed because it is effective, affordable, and generally safe.
In recent years, researchers have become interested in whether metformin might have other health benefits beyond diabetes control. Some earlier studies suggested it might help reduce the risk of certain cancers. The new study adds more evidence to this idea, focusing specifically on skin cancer.
The research was led by Dr. Tiffany Libby, an assistant professor of dermatology at Brown University. The findings were published in the Journal of Drugs in Dermatology.
In the study, researchers used a large health database from the National Institutes of Health. They examined records from more than 8,000 people with basal cell carcinoma and over 4,100 people with squamous cell carcinoma.
Each person with cancer was matched with four healthy individuals who were similar in age, sex, race, and ethnicity. This helped ensure that the comparison was fair and reliable.
The results showed that people who were taking metformin had a significantly lower risk of developing both types of skin cancer. This protective effect remained even after the researchers considered other medications that might affect cancer risk.
However, the study also found an important exception. Black patients who were taking metformin did not show the same reduced risk of squamous cell carcinoma.
The researchers believe this may be because squamous cell carcinoma in Black patients often develops in areas of the body that are not exposed to the sun. In these cases, the cancer may be more closely linked to long-term inflammation or scarring, which metformin may not fully address.
Scientists are still trying to understand exactly how metformin might protect against cancer. There are several possible explanations based on how the drug works in the body.
One idea is that metformin may slow down the growth of cancer cells by limiting their access to energy. Cancer cells need a lot of energy to grow and spread, and metformin may make this process more difficult.
Another possibility is that metformin helps the body remove damaged or unhealthy cells. By promoting the natural death of these cells, the drug may prevent them from turning into cancer.
Metformin may also reduce inflammation in the body. Chronic inflammation is known to increase the risk of cancer, so lowering inflammation could help protect against it.
In addition, metformin may stop tumors from developing their own blood supply. Tumors need blood vessels to deliver nutrients and oxygen. By blocking this process, metformin may slow or prevent tumor growth.
Although these findings are promising, the researchers caution that more studies are needed. Scientists need to better understand how metformin works in different groups of people and whether it can be safely used as a preventive treatment for skin cancer.
This study suggests that metformin may offer benefits beyond its role in diabetes care. If future research confirms these results, it could become an important tool in reducing the risk of common skin cancers.
The findings were published in the Journal of Drugs in Dermatology. As research continues, this widely used drug may play a new role in protecting skin health and preventing cancer.
If you care about diabetes, please read studies about diabetes and vitamin B12, and the right diet for people with type 2 diabetes.
For more health information, please see recent studies about how to eat smart with diabetes, and turmeric and vitamin D: a duo for blood pressure control in diabetic patients.
Copyright © 2026 Knowridge Science Report. All rights reserved.
